IL23R: A susceptibility locus for celiac disease and multiple sclerosis?

Genes and Immunity

Volumn 9, Issue 4, 2008, Pages 289-293

  Nunez C ^a   Dema, B ^a   Cenit M C ^a   Polanco, I ^b   Maluenda, C ^a   Arroyo, R ^a   de las Heras, V ^a   Bartolome M ^a   de la Concha, E G ^a   Urcelay, E ^a   Martinez A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12P40; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN RECEPTOR;

ARTICLE; CASE CONTROL STUDY; CELIAC DISEASE; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CELIAC DISEASE; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; VARIATION (GENETICS);

EID: 44849127017     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.16     Document Type: Article

References (28)

1. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-725.
2. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8 950-957.
3. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463.
4. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP et al A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-290.
5. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39 1329-1337.
6. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551-563.
7. Kahl KG, Kruse N, Toyka KV, Rieckmann P. Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis. J Neurol Sci 2002; 200: 53-55.
8. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-911.
9. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
10. Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F et al. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol 2007 [E-pub ahead of print].
11. Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J et al The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 2007; 68: 934-937.
12. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341-1344.
13. Hunt KA, Monsuur AJ, McArdle WL, Kumar PJ, Travis SP, Walters JR et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006; 55: 969-972.
14. Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999; 53: 1361-1363.
15. Martinez A, Rubio A, Urcelay E, Fernandez-Arquero M, De Las Heras V, Arroyo R et al. TNF-376A marks susceptibility to MS in the Spanish population: A replication study. Neurology 2004; 62: 809-810.
16. Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric crohn's disease. Clin Gastroenterol Hepatol 2007; 5: 972-976.
17. Borgiani P, Perricone C, Ciccacci C, Romano S, Novelli G, Biancone L et al. Interleukin-23R Arg381Gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population. Gastroenterology 2007; 133: 1049-1051; author reply 1051-1042.
18. Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L et al Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis 2007; 13: 1063-1068.
19. Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A et al IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis 2007; 13: 511-515.
20. Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A et al. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 2007; 132: 1657-1664.
21. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Davies G et al. IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 2007; 56: 1173-1174.
22. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13. 1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007; 52: 575-583.
23. Glas J, Seiderer J, Wetzke M, Konrad A, Torok HP, Schmechel S et al rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: Combined analysis of IL23R, CARD15, and OCTN1/ 2 variants. PLoS ONE 2007; 2: E819.
24. Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, Van Eerdewegh P et al. Genome-wide association study for Crohn's disease in the Quebec founder population identifies multiple validated disease loci. Proc Natl Acad Sci USA 2007; 104: 14747-14752.
25. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
26. Heremans H, Dillen C, Groenen M, Martens E, Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: Enhancement by monoclonal antibodies against interferon-gamma. Eur J Immunol 1996; 26: 2393-2398.
27. Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893-895.
28. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.